BDX vs RMD — Key Metrics
| Metric | BDX (BECTON DICKINSON & CO) | RMD (RESMED INC) |
|---|---|---|
| Price | 216.08 | 242.61 |
| Market Cap | 58.86 Billion | 34.12 Billion |
| P/E (TTM) | 65.08 | 22.04 |
| P/B (Quarterly) | 1.975 | 5.438 |
| P/S (TTM) | 2.82 | 5.95 |
| Net Profit Margin (TTM) | 4.5 | 27.8 |
| Gross Margin (TTM) | 46.4 | 61.1 |
| ROE (TTM) | 3.8 | 25.1 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Outperform
Recommendation Summary
BDX is not scored by the AI model, which covers non-financial S&P 500 companies (banks, insurers and asset managers report on a different basis), so there is no recommendation for this pair.
Financial Metrics
| BDX | Metrics | RMD |
|---|---|---|
| $216.08 | Price | $242.61 |
| — | Market Capitalization | — |
| 65.08 | Price to Earnings Ratio | 22.04 |
| 2.82 | Price to Sales | 5.95 |
| 23.25 | Price to FCF Ratio | 21.21 |
| 6.08 | Price to Gross Profit | 9.75 |
| 51.86 | Price to R&D | 86.65 |
| 7.23 | Price to Current Assets | 9.73 |
BDX vs RMD at a glance
Becton Dickinson & CO (BDX) and Resmed INC (RMD) are both Medical Instruments & Supplies companies in the Healthcare sector. BDX is the larger, at $58.9 billion in market value against $34.1 billion for RMD, about 1.7 times the size.
On trailing-twelve-month figures, BDX trades at 65.1 times trailing earnings and RMD at 22.0; net profit margins are 4.5% and 27.8%.